AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL – Get Free Report) was the recipient of a large decline in short interest during the month of October. As of October 30th, there was short interest totaling 469,259 shares, a decline of 66.2% from the October 15th total of 1,388,145 shares. Based on an average daily volume of 1,505,842 shares, the short-interest ratio is currently 0.3 days. Approximately 1.7% of the company’s shares are short sold.
Institutional Trading of AGF U.S. Market Neutral Anti-Beta Fund
Institutional investors have recently bought and sold shares of the business. CoreCap Advisors LLC bought a new stake in shares of AGF U.S. Market Neutral Anti-Beta Fund during the 2nd quarter valued at $36,000. Bank of New York Mellon Corp raised its holdings in AGF U.S. Market Neutral Anti-Beta Fund by 59.4% during the 1st quarter. Bank of New York Mellon Corp now owns 27,235 shares of the company’s stock worth $380,000 after buying an additional 10,146 shares during the period. Farther Finance Advisors LLC lifted its position in AGF U.S. Market Neutral Anti-Beta Fund by 939.7% in the 3rd quarter. Farther Finance Advisors LLC now owns 42,356 shares of the company’s stock valued at $508,000 after acquiring an additional 38,282 shares in the last quarter. Collaborative Fund Advisors LLC bought a new stake in shares of AGF U.S. Market Neutral Anti-Beta Fund in the third quarter valued at about $1,794,000. Finally, Crescent Grove Advisors LLC acquired a new position in AGF U.S. Market Neutral Anti-Beta Fund during the 1st quarter worth approximately $6,614,000.
AGF U.S. Market Neutral Anti-Beta Fund Stock Performance
NYSEARCA BTAL opened at $13.26 on Friday. The stock has a market capitalization of $379.90 million, a P/E ratio of 17.49 and a beta of -0.68. AGF U.S. Market Neutral Anti-Beta Fund has a 52 week low of $10.86 and a 52 week high of $16.14. The stock has a fifty day moving average of $12.56 and a 200-day moving average of $12.65.
About AGF U.S. Market Neutral Anti-Beta Fund
The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.
Further Reading
- Five stocks we like better than AGF U.S. Market Neutral Anti-Beta Fund
- Golden Dome’s $185 Billion Question: Who Actually Gets Paid?
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
Receive News & Ratings for AGF U.S. Market Neutral Anti-Beta Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AGF U.S. Market Neutral Anti-Beta Fund and related companies with MarketBeat.com's FREE daily email newsletter.
